Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing in prevalence of cardiovascular diseases
3.2.1.2 Growing technological advancement
3.2.1.3 Rising prevalence of hypertension
3.2.1.4 Favorable reimbursement scenario
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with surgery procedures
3.2.2.2 Complications associated with the surgery
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Method, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Traditional (on-pump) CABG
5.3 Minimally invasive direct CABG
5.3.1 Off-pump CABG
5.3.2 Keyhole CABG
5.3.3 Other minimally invasive CABG surgery types
Chapter 6 Market Estimates and Forecast, By Surgery Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Single CABG surgery
6.3 Double CABG surgery
6.4 Triple CABG surgery
6.5 Quadruple CABG surgery
Chapter 7 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Grafts
7.2.1 Saphenous vein grafts
7.2.2 Internal thoracic artery grafts
7.2.3 Other grafts
7.3 Retractors
7.4 Heart positioners
7.5 Tissue stabilizers
7.6 Other products
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Cardiology centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Mexico
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Edwards Lifesciences Corporation
10.2 Getinge AB
10.3 Genesee Biomedical
10.4 Guidant Corporation
10.5 LivaNova PLC
10.6 Medtronic plc
10.7 Novadaq Technologies Inc.
10.8 Stryker Corporation
10.9 Teleflex Incorporated
10.10 Terumo Corporation
